Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 31;15(5):2349-2352.
doi: 10.21037/jgo-24-284. Epub 2024 Oct 29.

Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?

Carles Pericay  1 , Julen Fernández-Plana  1
Affiliations
Editorial

Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?

Carles Pericay et al. J Gastrointest Oncol. .
No abstract available

Keywords: Metastatic colorectal cancer (mCRC); RAS wild-type (RAS WT); negative hyperselection; panitumumab.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-24-284/coif). C.P. reports honoraria by Merck and Astrazeneca; and reports support for attending meetings and travel by MSD. J.F.P. reports support for attending meetings and travel by Merck. The authors have no other conflicts of interest to declare.

Comment on

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. 10.3322/caac.21660 - DOI - PubMed
    1. Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann Oncol 2018;29:1016-22. 10.1093/annonc/mdy033 - DOI - PubMed
    1. Morris VK, Kennedy EB, Baxter NN, et al. Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J Clin Oncol 2023;41:678-700. 10.1200/JCO.22.01690 - DOI - PMC - PubMed
    1. Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023;34:10-32. 10.1016/j.annonc.2022.10.003 - DOI - PubMed
    1. Otsu S, Hironaka S. Current Status of Angiogenesis Inhibitors as Second-Line Treatment for Unresectable Colorectal Cancer. Cancers (Basel) 2023;15:4564. 10.3390/cancers15184564 - DOI - PMC - PubMed

LinkOut - more resources